Show simple item record

dc.contributor.authorGranjo, Een_US
dc.contributor.authorLima, Men_US
dc.contributor.authorCorreia, Ten_US
dc.contributor.authorLisboa, Cen_US
dc.contributor.authorMagalhães, Cen_US
dc.contributor.authorCunha, Nen_US
dc.contributor.authorTeixeira, MAen_US
dc.contributor.authorQueirós, MLen_US
dc.contributor.authorCandeias, Jen_US
dc.contributor.authorMatutes, Een_US
dc.date.accessioned2018-09-17T15:17:23Z
dc.identifier2en_US
dc.identifier.citationHematological Oncology, 20 pp. 87 - 93en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2744
dc.identifier.doi10.1002/hon.695en_US
dc.description.abstractAbstract We report a case of CD8+/Vβ5.1+ T-cell large granular lymphocyte leukemia (T-LGL leukemia) presenting with mild lymphocytosis, severe autoimmune neutropenia, thrombocytopenia, polyarthritis and recurrent infections with a chronic disease course. Immunophenotyping showed an expansion of CD3+/TCRαβ+/CD8+bright/CD11c+/CD57−/CD56− large granular lymphocytes with expression of the TCR-Vβ5.1 family. Southern blot analysis revealed a clonal rearrangement of the TCR β-chain gene. Hematopoietic growth factors, high dose intravenous immunoglobulin and corticosteroids were of limited therapeutic benefit to correct the cytopenias. During the disease course, the patient developed a severe cutaneous leg ulcer and bilateral vascular mammary skin lesions. Treatment with 2-deoxycoformycin resulted in both clinical and hematological complete responses, including the resolution of vascular skin lesions. Combined immuno-staining with relevant T-cell associated and anti-TCR-Vβ monoclonal antibodies proved to be a sensitive method to assess the therapeutic effect of 2-deoxycoformicin and to evaluate the residual disease. Copyright © 2002 John Wiley & Sons, Ltd.en_US
dc.format.extent87 - 93en_US
dc.titleCd8+/vβ5.1+ large granular lymphocyte leukemia associated with autoimmune cytopenias, rheumatoid arthritis and vascular mammary skin lesions: successful response to 2-deoxycoformycin.en_US
dc.typeJournal Article
dcterms.dateAccepted2002-03-22en_US
rioxxterms.versionofrecord10.1002/hon.695en_US
rioxxterms.licenseref.urien_US
rioxxterms.licenseref.startdate2002-03-22en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfHematological Oncologyen_US
pubs.noteskeywords: rheumatoid arthritis, large granular lymphocytes, CD8+, skin lesions, autoimmune cytopenias, 2-deoxycoformycinen_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Molecular Haematology (including Cytogenetics Group and Cell Markers)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular Haematology (including Cytogenetics Group and Cell Markers)
pubs.volume20en_US
pubs.embargo.termsNot knownen_US
icr.researchteamMolecular Haematology (including Cytogenetics Group and Cell Markers)en_US
dc.contributor.icrauthorMatutes, Estellaen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record